Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Edwards Lifesciences acquires Vectorious for $497M

PRIVATESep 04, 2025

Acquiring Company

Edwards Lifesciences

Acquired Company

Vectorious Medical Technologies

IrvineTel AvivManufacturingBiotechnologyHealthcareHealth CareArtificial IntelligenceMedicalMedical DeviceBiotechnologyHealth CareMedical

Description

Edwards Lifesciences has finalized its $497 million acquisition of Vectorious Medical Technologies. This transaction follows a previous investment where Edwards acquired a 52% stake. With this deal, Edwards now fully owns Vectorious, which specializes in heart failure treatment technology. The acquisition aims to enhance Edwards' offerings in the medical device sector.

Company Information

Company

Edwards Lifesciences

Location

One Edwards Way

Irvine, California, United States

About

Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. The company is dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.

Fundz sees it the moment Edwards Lifesciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Tiago
Likely contact at this company
••••••••@••••••••

See Tiago's verified email →

Pierre
Senior decision-maker at this company
••••••••@••••••••

See Pierre's verified email →

Amy
Senior decision-maker at this company
••••••••@••••••••

See Amy's verified email →

Sannaa
Likely contact at this company
••••••••@••••••••

See Sannaa's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Edwards Lifesciences's next move

Learn about Strategic plan

Frequently asked

Who acquired Vectorious Medical Technologies?

Vectorious Medical Technologies was acquired by Edwards Lifesciences, based in Irvine. The deal was reported on September 4, 2025. Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. Edwards Lifesciences is privately held and operates in Manufacturing.

When did Edwards Lifesciences acquire Vectorious Medical Technologies?

Edwards Lifesciences's acquisition of Vectorious Medical Technologies was reported on September 4, 2025. Edwards Lifesciences has finalized its $497 million acquisition of Vectorious Medical Technologies. This transaction follows a previous investment where Edwards acquired a 52% stake. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Vectorious Medical Technologies do?

Vectorious Medical Technologies develops novel treatment for heart failure patients which is based on physician directed, patients’ self-management paradigm. It is privately held, operating in Biotechnology, and is based in Tel Aviv.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.